Labor Market Pulse · Life Sciences · October 2026
Life Sciences Labor Market Report: WY NONMETROPOLITAN AREA — October 2026
Wyoming's thin bench masks itself in falling posted pay.
Advertised pay for Research Scientist ($119,606) and Regulatory Affairs Specialist ($88,778) fell sharply against national medians even as Wyoming's 3.0% unemployment rate signals a labor pool too tight to need broad posting.
Free archive edition. Published by WageScape as sent to subscribers; data as of October 2026.
Key indicators
- Wyoming nonmetro unemployment: 3.0% — vs 4.2% U.S. rate, Sept 2026
- Teton County unemployment: 1.8% — Lowest in Wyoming, Sept 2026
- Research Scientist advertised pay: $119,606 — Down significantly vs $130,339 national
- Lab/R&D vacancy rate: 23.2% — Top 13 U.S. life sci markets, Q1 2026
Key takeaways
Falling advertised pay here does not mean falling value.
Research Scientist, Regulatory Affairs Specialist, and Biostatistician postings all dropped significantly against rising or stable national medians. A 3.0% unemployment rate makes broad-based posting unnecessary for employers who already know where to find candidates, so advertised figures likely understate true market rates.
Clinical Data Manager is the outlier worth watching.
Local advertised pay rose moderately to $115,333, bucking the metro-wide decline across other scientific roles. Demand for data management expertise appears resilient even as broader R&D and regulatory postings soften, suggesting this function deserves separate benchmarking treatment apart from other clinical roles.
Leadership-tier scarcity is driving a retention premium.
Director roles in regenerative medicine span $72K–$150K while Laboratory Scientist II starts near $35.12/hour, an unusually wide band that signals leadership-track talent is the acute shortage point, with entry-level staff facing comparatively less pressure. Retention budgets should weight experienced scientists and regulatory leads over broad-based raises.
Outsourcing math favors CROs and CDMOs for now.
Mining's continued decline (down 2.5% in Q2) confirms no skilled manufacturing labor is migrating into life sciences, while national data shows lab and R&D vacancy rates near 23%. Build-vs-outsource decisions for manufacturing and early-stage clinical work likely tilt toward external partners until local supply conditions change.
Median advertised pay by role — WY NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $119,606 | $124,678 | Significant decline | $130,339 |
| Clinical Research Associate | $104,176 | $112,193 | $127,080 | Moderate decline | $90,065 |
| Lab Technician * | $37,409 | $37,853 | $71,563 | Significant decline | $47,840 |
| Regulatory Affairs Specialist * | $86,745 | $88,778 | $91,320 | Significant decline | $103,780 |
| Clinical Data Manager * | $99,798 | $115,333 | $121,294 | Moderate increase | $123,653 |
| Biostatistician | $93,655 | $108,556 | $144,886 | Significant decline | $131,958 |
| Validation Engineer | — | — | — | No data | $106,478 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Wyoming nonmetropolitan counties held unemployment at a tight 3.0% in September, with Teton (1.8%), Crook and Albany (2.2%) counties posting rates far below the 4.2% national figure, compressing an already thin pipeline for credentialed scientific and regulatory talent. Private education and health services expansion (up 2.5% in Q2) is pulling general labor supply toward competing sectors just as mining continues to shed workers, offering no spillover of technical talent into life sciences roles.
What it means
Advertised pay for Research Scientist, Regulatory Affairs Specialist, and Biostatistician roles all declined significantly against national medians this month, a pattern consistent with employers pulling back on posted rates in a market where candidate supply is scarce enough that fewer new postings are needed to fill roles; this reflects posting behavior, and market value may still hold. Director-level regenerative medicine roles commanding $72K–$150K alongside falling advertised rates for mid-tier scientific roles points toward bifurcation: retention dollars are concentrating at the leadership tier while entry and mid-level pay softens. Organizations should evaluate whether declining local advertised pay for CRA and regulatory roles reflects reduced competition for talent or simply fewer postings in a market too tight to advertise broadly, before adjusting compensation bands downward.
Looking ahead
Expected: Wyoming's October unemployment figures publish November 23 — watch whether the 3.0% statewide rate holds or tightens further, which would sharpen competition for the limited pool of regulatory and clinical talent across nonmetro counties.
Emerging pressure point: Bechtel's October split from the TerraPower Natrium project introduces a pool of technical and project-management talent into the Wyoming labor market. Life sci manufacturing and quality leaders should watch whether any of that talent has transferable credentials for biomanufacturing or facilities roles.
Worth watching: National biopharma hiring sentiment is firming, with 64% of organizations actively recruiting and layoffs down sharply year-over-year. If that national demand reaches Wyoming employers, expect renewed competition for the same thin bench of experienced CRAs and regulatory specialists already in short supply locally.
Potential inflection point: EUDAMED and EU AI Act compliance deadlines are driving premium pay for regulatory and compliance talent nationally. Wyoming employers with EU-market products should budget for this pressure to reach domestic regulatory affairs postings even without direct EU operations.
Sources
- Wyoming Department of Workforce Services — Wyoming nonmetro unemployment and county-level rates for September 2026
- Wyoming Division of Economic Analysis — Private education and health services employment growth of 2.5% in Q2 2026
- Research & Planning, Wyoming DWS — Director-level regenerative medicine pay range of $72K-$150K in Wyoming
- Industry life sciences labor market research — Lab/R&D vacancy rate of 23.2% across top 13 U.S. life sciences markets
- Wyoming state news reporting — Bechtel split from TerraPower Natrium project, WARN filing October 2026
- Bureau of Labor Statistics — National unemployment rate of 4.2% for comparison
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.